Rhône-Poulenc Rorer
E902895
Rhône-Poulenc Rorer was a major French-American pharmaceutical company known for developing important cancer therapies and later becoming part of Sanofi through mergers.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Rhône-Poulenc Rorer canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T11074694 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Rhône-Poulenc Rorer Context triple: [Docetaxel, developedBy, Rhône-Poulenc Rorer]
-
A.
Smith, Kline & French
Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
-
B.
Schering
Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
-
C.
Roche
Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
-
D.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
E.
Ciba-Geigy
Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Rhône-Poulenc Rorer Target entity description: Rhône-Poulenc Rorer was a major French-American pharmaceutical company known for developing important cancer therapies and later becoming part of Sanofi through mergers.
-
A.
Smith, Kline & French
Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
-
B.
Schering
Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
-
C.
Roche
Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
-
D.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
E.
Ciba-Geigy
Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
- F. None of above. chosen
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
pharmaceutical company ⓘ |
| areaServed | worldwide ⓘ |
| countryOfOrigin |
France
ⓘ
United States of America ⓘ
surface form:
United States
|
| eventuallyPartOf | Sanofi NERFINISHED ⓘ |
| fate |
became part of Sanofi
ⓘ
merged into Aventis ⓘ |
| hasDivision |
manufacturing
ⓘ
marketing and sales ⓘ research and development ⓘ |
| hasMajorShareholder | Rhône-Poulenc SA NERFINISHED ⓘ |
| hasParentCompany | Rhône-Poulenc SA NERFINISHED ⓘ |
| hasResearchFocus |
cardiology
ⓘ
central nervous system disorders ⓘ metabolic diseases ⓘ oncology ⓘ respiratory diseases ⓘ |
| hasSuccessorOrganization |
Aventis Pharma
NERFINISHED
ⓘ
Sanofi-Aventis NERFINISHED ⓘ |
| headquartersLocation |
France
ⓘ
United States of America ⓘ
surface form:
United States
|
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| knownAs | RPR NERFINISHED ⓘ |
| languageOfName |
English
ⓘ
French ⓘ |
| mergedInto | Aventis NERFINISHED ⓘ |
| notableFor |
cardiovascular drugs
ⓘ
central nervous system drugs ⓘ development of cancer therapies ⓘ oncology research ⓘ |
| operatedIn |
Asia
NERFINISHED
ⓘ
Europe NERFINISHED ⓘ North America NERFINISHED ⓘ |
| parentCompany | Rhône-Poulenc NERFINISHED ⓘ |
| partOf | Rhône-Poulenc group NERFINISHED ⓘ |
| predecessor |
Rhône-Poulenc
NERFINISHED
ⓘ
Rorer NERFINISHED ⓘ |
| productType |
CNS drugs
ⓘ
cardiovascular drugs ⓘ oncology drugs ⓘ prescription drugs ⓘ |
| successor |
Aventis
NERFINISHED
ⓘ
Sanofi NERFINISHED ⓘ |
| typeOfBusiness | multinational corporation ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Rhône-Poulenc Rorer Description of subject: Rhône-Poulenc Rorer was a major French-American pharmaceutical company known for developing important cancer therapies and later becoming part of Sanofi through mergers.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject surface form:
Docetaxel